Dantrium
NDC 42023-124, dantrolene sodium, capsule, from Par Health USA, LLC.
- Product NDC
- 42023-124
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017443
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42023-124 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANTROLENE SODIUM25 mg/1
Pharmacologic classes
Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42023-124-01 | 42023012401 | 100 CAPSULE in 1 BOTTLE (42023-124-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/57b4eec1-49e1-432c-95ae-0fe36e32d64b
Use it
Look up 42023-124 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42023-124 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42023-124. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.